Schechter Investment Advisors LLC Purchases 3,271 Shares of Ingevity Co. (NYSE:NGVT)

Schechter Investment Advisors LLC raised its position in shares of Ingevity Co. (NYSE:NGVT) by 12.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,876 shares of the company’s stock after acquiring an additional 3,271 shares during the quarter. Schechter Investment Advisors LLC’s holdings in Ingevity were worth $1,217,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of NGVT. Louisiana State Employees Retirement System raised its holdings in shares of Ingevity by 3.5% during the third quarter. Louisiana State Employees Retirement System now owns 17,600 shares of the company’s stock valued at $686,000 after purchasing an additional 600 shares during the period. State of Alaska Department of Revenue raised its holdings in shares of Ingevity by 4.6% during the third quarter. State of Alaska Department of Revenue now owns 20,745 shares of the company’s stock valued at $809,000 after purchasing an additional 908 shares during the period. Nisa Investment Advisors LLC raised its holdings in shares of Ingevity by 27.3% during the third quarter. Nisa Investment Advisors LLC now owns 3,880 shares of the company’s stock valued at $151,000 after purchasing an additional 831 shares during the period. Amalgamated Bank raised its holdings in shares of Ingevity by 2.4% during the third quarter. Amalgamated Bank now owns 10,667 shares of the company’s stock valued at $416,000 after purchasing an additional 246 shares during the period. Finally, Patten & Patten Inc. TN raised its holdings in shares of Ingevity by 17.7% during the third quarter. Patten & Patten Inc. TN now owns 212,015 shares of the company’s stock valued at $8,269,000 after purchasing an additional 31,959 shares during the period. Institutional investors own 91.59% of the company’s stock.

Ingevity Trading Down 5.1 %

NGVT opened at $45.25 on Tuesday. Ingevity Co. has a fifty-two week low of $30.90 and a fifty-two week high of $56.29. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. The company’s 50-day moving average is $43.86 and its 200 day moving average is $41.61. The firm has a market capitalization of $1.64 billion, a PE ratio of -3.82 and a beta of 1.64.

Ingevity (NYSE:NGVT) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.66. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The business had revenue of $298.80 million during the quarter, compared to the consensus estimate of $297.40 million. As a group, research analysts predict that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

NGVT has been the topic of several research reports. StockNews.com upgraded shares of Ingevity from a “hold” rating to a “buy” rating in a report on Thursday, February 20th. BMO Capital Markets upgraded shares of Ingevity from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $62.00 to $65.00 in a report on Wednesday, February 26th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Ingevity currently has a consensus rating of “Moderate Buy” and an average target price of $55.17.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.